MASTER AGREEMENTMaster Agreement • September 10th, 2008 • Eugene Science • Pharmaceutical preparations • Minnesota
THIS MASTER AGREEMENT (this “Agreement”), dated effective as of August 19, 2008 (the “Effective Date”), is made by and among Eugene Science Inc., a Delaware corporation (“Eugene”); KIP Biotech, LLC, a Delaware limited liability company (“KIP”); Onbio Corporation, a Republic of Korea corporation (“Onbio”); Seung-Kwon Noh (“Noh”); ASA Opportunity Fund L.P., a Delaware limited partnership, Bradley Rotter, Zhonghua Chen, Scott Choi, Kang Du (collectively, the “Lenders”) and Benton H. Wilcoxon (“Wilcoxon,” collectively with the Lenders, “Creditors”).
